J. Meynard

发表

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)

C. Fagard, Y. Yazdanpanah, B. Spire, 2018, The Journal of antimicrobial chemotherapy.

Common Knowledge and Accounting.PDF

S. Sunder, Joan Luft, J. Meynard, 1999 .

Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France

D. Costagliola, S. Grabar, O. Launay, 2018, PloS one.

Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France

D. Costagliola, S. Grabar, O. Launay, 2016, AIDS.

Herpes simplex esophagitis in patients with AIDS: report of 34 cases. The Cooperative Study Group on Herpetic Esophagitis in HIV Infection.

O. Lortholary, L. Guillevin, R. Verdon, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results

J. Poirier, K. Lacombe, A. Boyd, 2013, AIDS.

Two-Year Observational Study in Patients Infected with Drug-Resistant HIV-1 and Treated with the Fusion Inhibitor Enfuvirtide: The ZOOM Cohort

G. Chêne, P. Girard, J. Meynard, 2011 .

Low Frequency of Intermittent HIV-1 Semen Excretion in Patients Treated with Darunavir-Ritonavir at 600/100 Milligrams Twice a Day plus Two Nucleoside Reverse Transcriptase Inhibitors or Monotherapy

V. Calvez, C. Katlama, G. Peytavin, 2010, Antimicrobial Agents and Chemotherapy.

Report of disseminated Mycobacterium haemophilum infection after double cord blood allo-SCT

M. Mohty, O. Legrand, V. Lalande, 2014, Bone Marrow Transplantation.

INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels

V. Calvez, C. Katlama, A. Boyd, 2019, Open forum infectious diseases.

Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

V. Calvez, C. Katlama, J. Izopet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?

V. Calvez, P. Muret, G. Peytavin, 2017, The Journal of antimicrobial chemotherapy.

Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis

E. Negredo, P. Vernazza, P. Cahn, 2011, PloS one.

Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial.

J. Izopet, G. Chêne, S. Kolta, 2010, The Journal of antimicrobial chemotherapy.

Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.

J. Poirier, K. Lacombe, P. Girard, 2009, The Journal of antimicrobial chemotherapy.

Increased carotid intima–media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients

A. Samri, B. Autran, V. Appay, 2015, AIDS.

Risk factors for ‘unmasking immune reconstitution inflammatory syndrome’ presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients

K. Lacombe, V. Lalande, P. Girard, 2010, AIDS.

Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients

J. Capeau, J. Bastard, M. Lemoine, 2017, AIDS.

Response to: ‘Does the prevalence of radiographic hand osteoarthritis in patients with HIV-1 infection increase or not?’ by Luo et al

D. Felson, F. Berenbaum, J. Capeau, 2016, Annals of the rheumatic diseases.

Fanconi syndrome and renal failure induced by tenofovir: a first case report.

J. Rossert, B. Fouqueray, P. Ronco, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum

E. Bingen, J. Meynard, B. Carbonne, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients.

A. Boyd, P. Girard, C. Viala, 2015, Journal of acquired immune deficiency syndromes.

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis

E. Lanoy, P. Tiberghien, S. Grabar, 2022, Leukemia.

Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis

C. Lebbé, L. Galicier, O. Lambotte, 2010, AIDS.

Non-O:1 and non-O:139 Vibrio cholerae septicemia and pyomyositis in an immunodeficient traveler returning from Tunisia.

C. Couzigou, K. Lacombe, D. Vittecoq, 2007, Travel medicine and infectious disease.

Clostridium difficile associated reactive arthritis: Case report and literature review.

C. Eckert, F. Barbut, V. Lalande, 2016, Anaerobe.

Broncho‐Pulmonary Cryptosporidiosis in Four HIV‐Infected Patients

M. Antoine, P. Girard, J. Meynard, 1996, The Journal of eukaryotic microbiology.

Major Hypertriglyceridemia in HIV-Infected Patients on Antiretroviral Therapy: A Role of the Personal and Family History

M. Guiguet, J. Meynard, P. Benlian, 2004, Infection.

Human Immunodeficiency Virus‐Associated Thrombotic Microangiopathies: Clinical Characteristics and Outcome According to ADAMTS13 Activity

É. Azoulay, L. Galicier, C. Adrie, 2008, Scandinavian journal of immunology.

Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France

D. Costagliola, S. Grabar, O. Launay, 2015, PloS one.

Plasma HIV-RNA Is the Key Determinant of Long-Term Antibody Persistence After Yellow Fever Immunization in a Cohort of 364 HIV-Infected Patients

K. Lacombe, P. Girard, J. Meynard, 2012, Journal of acquired immune deficiency syndromes.

Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated Adults

A. Samri, B. Autran, J. Capeau, 2019, Open forum infectious diseases.

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses.

E. Denamur, O. Clermont, E. Bingen, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Sustained Increase of HDL Cholesterol Over a 72-Week Period in HIV-Infected Patients Exposed to an Antiretroviral Regimen Including Lopinavir/Ritonavir

J. Poirier, K. Lacombe, P. Benlian, 2008, Journal of the International Association of Physicians in AIDS Care.

Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study

C. Charpentier, Y. Yazdanpanah, D. Costagliola, 2022, BMC Infectious Diseases.

Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults.

C. Katlama, Y. Lévy, G. Chêne, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.

J. Poirier, G. Pialoux, P. Jaillon, 2006, AIDS.

Cellular CD 4 T Cell Responses to the Diphtheria-Derived Carrier Protein of Conjugated Pneumococcal Vaccine and Antibody Response to Pneumococcal Vaccination in HIV-Infected Adults

C. Katlama, Y. Lévy, G. Chêne, 2010 .

Presence of Minority Resistant Variants After Failure of a Tenofovir, Emtricitabine, and Rilpivirine Regimen

V. Calvez, J. Meynard, L. Morand‐Joubert, 2016, Journal of acquired immune deficiency syndromes.

Increased prevalence and severity of radiographic hand osteoarthritis in HIV-1- infected patients associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study

D. Felson, F. Berenbaum, J. Capeau, 2017 .

Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study

D. Felson, F. Berenbaum, J. Capeau, 2016, Annals of the rheumatic diseases.

Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases.

C. Katlama, G. Brücker, A. Datry, 1993, Journal of acquired immune deficiency syndromes.

Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients

C. Goujard, A. Taburet, J. Meynard, 2003, Antimicrobial Agents and Chemotherapy.

Diversity and combinations of infectious agents in 38 adults with an infection-triggered reactive haemophagocytic syndrome: a multicenter study.

É. Azoulay, L. Galicier, O. Lambotte, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Frequency and risk factors of infectious complications in neutropenic patients infected with HIV

M. Guiguet, J. Meynard, J. Frottier, 1997, AIDS.

Liver Fibrosis Changes in HIV–HBV-Coinfected Patients: Clinical, Biochemical and Histological Effect of Long-Term Tenofovir Disoproxil Fumarate Use

D. Wendum, J. Molina, K. Lacombe, 2010, Antiviral therapy.

Urolithiasis in HIV-positive patients treated with atazanavir.

D. Neau, M. Daudon, C. Couzigou, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The impact of CCL3L1 copy number in an HIV-1-infected white population

F. Lescure, J. Poirier, G. Pialoux, 2010, AIDS.

High Variability of Plasma Drug Concentrations in Dual Protease Inhibitor Regimens

W. Rozenbaum, J. Poirier, G. Pialoux, 2003, Antimicrobial Agents and Chemotherapy.

Campylobacter bacteremia: clinical features and factors associated with fatal outcome.

J. Mainardi, F. Doucet-Populaire, P. Legrand, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial

C. Katlama, M. Duracinsky, D. Costagliola, 2018, The Journal of antimicrobial chemotherapy.

Predictors of the Virological Response to a Change in the Antiretroviral Treatment Regimen in HIV-1-Infected Patients Enrolled in a Randomized Trial Comparing Genotyping, Phenotyping and Standard of Care (Narval Trial, Anrs 088)

F. Brun-Vézinet, D. Costagliola, F. Clavel, 2002, Antiviral therapy.

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

Pierre-Marie Girard, Françoise Brun-Vézinet, Diane Descamps, 2002, AIDS.

Cohort Profile Cohort Profile : French hospital database on HIV ( FHDH-ANRS CO 4 )

C. Katlama, M. Guiguet, D. Costagliola, 2014 .

Managing antibiotic associated diarrhoea

F. Barbut, J. Meynard, 2002, BMJ : British Medical Journal.

COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease

M. Mohty, B. Stankoff, D. Farge-Bancel, 2021, Current Research in Translational Medicine.

[Henoch-Schönlein purpura-like vasculitis revealing HIV infection].

J. Meynard, L. Fardet, S. Rivière, 2016, Medecine et maladies infectieuses.

Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads

A. Boyd, P. Girard, J. Meynard, 2018, The Journal of antimicrobial chemotherapy.

Boosted protease inhibitor monotherapy as a maintenance strategy: an observational study

M. Guiguet, D. Costagliola, O. Launay, 2012, AIDS.

Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial.

C. Delaugerre, C. Katlama, Y. Yazdanpanah, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy

M. Desvarieux, J. Capeau, A. Cohen, 2013, AIDS.

Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status

J. Ferrières, A. Wagner, D. Costagliola, 2019, PloS one.

Acquired haemophilia A associated with HIV infection: a rare disease.

T. Lambert, C. Goujard, C. Rivoisy, 2014, AIDS (London).

Atazanavir urinary stones in an HIV-infected patient.

I. Petit, J. Poirier, P. Girard, 2006, AIDS.

Screening HIV patients at risk for NAFLD using MRI-PDFF and transient elastography: a European multicenter prospective study.

C. Katlama, P. Bedossa, D. Costagliola, 2022, Clinical Gastroenterology and Hepatology.

Role of the Envelope Genetic Context in the Development of Enfuvirtide Resistance in Human Immunodeficiency Virus Type 1-Infected Patients

F. Mammano, F. Clavel, A. Hance, 2006, Journal of Virology.

Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.

C. Katlama, H. Melliez, D. Costagliola, 2023, The Journal of antimicrobial chemotherapy.

Clinically relevant interpretation of genotype for resistance to abacavir

V. Calvez, F. Brun-Vézinet, B. Masquelier, 2003, AIDS.

Liver Fibrosis Changes in HIV-HBV-Coinfected Patients: Clinical, Biochemical and Histological Effect of Long-Term Tenofovir Disoproxil Fumarate Use

D. Wendum, J. Molina, K. Lacombe, 2010 .

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression

R. Breban, A. Samri, C. Katlama, 2017, The Journal of antimicrobial chemotherapy.

Association of Residual Plasma Viremia and Intima-Media Thickness in Antiretroviral-Treated Patients with Controlled Human Immunodeficiency Virus Infection

A. Samri, M. Desvarieux, J. Capeau, 2014, PloS one.

Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial.

J. Poirier, K. Lacombe, M. Valantin, 2010, The Journal of antimicrobial chemotherapy.

Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient

M. Mohty, D. Boutolleau, B. Gaugler, 2022, Current Research in Translational Medicine.

Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum

B. Carbonne, V. Lalande, J. Meynard, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort

D. Costagliola, F. Boccara, Jean‐Marc Lacombe, 2015, PloS one.

Lack of interaction between atazanavir and proton pump inhibitors in HIV-infected patients treated with ritonavir-boosted atazanavir.

J. Poirier, J. Meynard, P. Bonnard, 2006, Journal of acquired immune deficiency syndromes.

Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis

C. Lebbé, L. Galicier, O. Lambotte, 2010, AIDS.

Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors.

M. Delmée, M. Guiguet, P. Tilleul, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients.

M. Guiguet, J. Meynard, F. Barbut, 1999, The Journal of infection.

Proton pump inhibitors do not reduce atazanavir concentrations in HIV-infected patients treated with ritonavir-boosted atazanavir.

J. Poirier, G. Pialoux, P. Jaillon, 2005, AIDS.

Plasma HIV-RNA Is the Key Determinant of Long-Term Antibody Persistence After Yellow Fever Immunization in a Cohort of 364 HIV-Infected Patients

K. Lacombe, P. Girard, J. Meynard, 2012, Journal of acquired immune deficiency syndromes.

Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)

B. Spire, G. Chêne, P. Girard, 2019, PharmacoEconomics - open.

Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.

C. Katlama, H. Melliez, D. Costagliola, 2023, The Journal of antimicrobial chemotherapy.

Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients.

A. Boyd, P. Girard, C. Viala, 2015, Journal of acquired immune deficiency syndromes.

Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients

J. Quenot, N. Lapidus, M. Neuville, 2024, Heliyon.